Novartis expands transplant portfolio with first branded generic tacrolimus The Pharma Letter Swiss drug major Novartis has announced the US introduction and availability of Hecoria (tacrolimus) capsules, the first generic tacrolimus that can be prescribed by its brand name. The drug is a copy of now off-patent Prograf from Japanese drugmaker ... |
